Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase

References

• Aderibigbe AO, Emudianughe TS, Lowal BA. (1999). Antihyper glycemic effect of Mangifera indica in rat. Phytother Res 13:504–7
   PubMed Web of Science ®Google Scholar
• Aderibigbe AO, Emudianughe TS, Lowal BA. (2001). Evaluation of antidiabetic action of Mangifera indica in mice. Phytother Res 15:456–8
   PubMed Web of Science ®Google Scholar
• Andreu GP, Delgado R, Curti JA, Vercesi AE. (2005). Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur J Pharm 513:47–55
   PubMed Web of Science ®Google Scholar
• Bock C, Ternes W. (2010). The phenolic acids from bacterial degradation of the mangiferin aglycone are quantified in the feces of pigs after oral ingestion of an extract of Cyclopia genistoides (honeybush tea). Nutr Res 30:348–57
   PubMed Web of Science ®Google Scholar
• Cleasby ME, Dzamko N, Hegarty BD, et al. (2004). Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 53:3258–66
   PubMed Web of Science ®Google Scholar
• Girón MD, Sevillano N, Salto R, et al. (2009). Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: Role of mangiferin. Clin Nutr 28:565–74
   PubMed Web of Science ®Google Scholar
• Han DD, Chen CJ, Zhang C, et al. (2010). Determination of mangiferin in rat plasma by liquid–liquid extraction with UPLC–MS/MS. J Pharmaceut Biomed 51:260–3
   PubMed Web of Science ®Google Scholar
• Hardie DG. (2004). The AMP-activated protein kinase pathway – New players upstream and downstream. J Cell Sci 117:5479–87
   PubMed Web of Science ®Google Scholar
• Hardie DG, Carling D. (1997). The AMP-activated protein kinase fuel gauge of the mammalian cell? Eur J Biochem 246:259–73.
   PubMedGoogle Scholar
• Hotamisligil GS. (2006). Inflammation and metabolic disorders. Nature 444:860–7
   PubMed Web of Science ®Google Scholar
• Huang TH, Peng G, Li GQ, et al. (2006). Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: Activation of PPAR-alpha. Toxicol Appl Pharm 210:225–35
   PubMed Web of Science ®Google Scholar
• Hu HG, Wang MJ, Zhao QJ, et al. (2007). Synthesis of mangiferin derivatives as protein tyrosine phosphatase 1B inhibitors. Chem Nat Compd 43:663–6
   Web of Science ®Google Scholar
• Ichiki H, Miura T, Kubo M, et al. (1998). New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 21:1389–90
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, et al. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–89
   PubMed Web of Science ®Google Scholar
• Koistinen HA, Galuska D, Chibalin AV, et al. (2003). 5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52:1066–72
   PubMed Web of Science ®Google Scholar
• Krook A, Wallberg-Henriksson H, Zierath JR. (2004). Sending the signal: Molecular mechanism regulating glucose uptake. Med Sci Sport Exer 36:1212–17
   PubMed Web of Science ®Google Scholar
• Li HY, Miyahara T, Tezuka Y, et al. (1998). The effect of kampo formulae on bone resorption in vitro and in vivo. Biol Pharm Bull 21:1322–6
   PubMed Web of Science ®Google Scholar
• Li Y, Peng G, Li Q, et al. (2004). Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci 75:1735–46
   PubMed Web of Science ®Google Scholar
• Liu HH, Wang K, Tang YH, et al. (2011). Structure elucidation of in vivo and in vitro metabolites of mangiferin. J Pharmaceut Biomed 55:1075–82
   PubMed Web of Science ®Google Scholar
• Mitsumoto Y, Klip A. (1992). Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 267:4957–62
   PubMed Web of Science ®Google Scholar
• Miura T, Ichiki H, Iwamoto N, et al. (2001a). Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biol Pharm Bull 24:1009–11
   PubMed Web of Science ®Google Scholar
• Miura T, Iwamoto N, Kato M, et al. (2001b). The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes. Biol Pharm Bull 24:1091–2
   PubMed Web of Science ®Google Scholar
• Moller DE, Flier JS. (1992). Insulin resistance: Mechanisms, syndromes, and implications. New Engl J Med 325:938–42
   Web of Science ®Google Scholar
• Moller DE. (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821–7
   PubMed Web of Science ®Google Scholar
• Mueller WM, Stanhope KL, Gregoire F, et al. (2000). Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 8:530–9
   PubMedGoogle Scholar
• Muruganandan S, Srinivasan K, Gupta S, et al. (2005). Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97:497–501
   PubMed Web of Science ®Google Scholar
• Pardo-Andreu GL, Sanchez-Baldoquin C, Avila-Gonzalez R, et al. (2006). Fe (III) improves antioxidant and cytoprotecting activities of mangiferin. Eur J Pharm 547:31–6
   PubMed Web of Science ®Google Scholar
• Petersen KF, Shulman GI. (2006). New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity 14:34S–40S
   PubMed Web of Science ®Google Scholar
• Sanugul K, Akao T, Li Y, et al. (2005). Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond. Biol Pharm Bull 28:1672–8
   PubMed Web of Science ®Google Scholar
• Smyth S, Heron A. (2006). Diabetes and obesity: The twin epidemics. Nat Med 12:75–80
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. (2006). Critical nodes in insulin signaling pathways: Insight into insulin action. Nat Rev Mol Cell Biol 7:85–96
   PubMed Web of Science ®Google Scholar
• Tan MJ, Ye JM, Turner N, et al. (2008). Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15:263–73
   PubMed Web of Science ®Google Scholar
• Walker PS, Ramlals T, Donovan JA, et al. (1989). Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line. J Biol Chem 264:6587–95
   PubMed Web of Science ®Google Scholar
• Wang H, Ye G, Tang YH, et al. (2006). High-performance liquid chromatographic method for the determination of mangiferin in rat plasma and urine. Biomed Chromatogr 20:1304–8
   PubMed Web of Science ®Google Scholar
• Wang H, Ye G, Ma CH, et al. (2007). Identification and determination of four metabolites of mangiferin in rat urine. J Pharm Biomed 45:793–8
   PubMed Web of Science ®Google Scholar
• Ye JM, Ruderman NB, Kraegen EW. (2005). AMP-activated protein kinase and malonyl-CoA: Targets for treating insulin resistance? Drug Discov Today 2:157–63
   Google Scholar
• Yin J, Hu R, Chen M, et al. (2002). Effects of berberine on glucose metabolism in vitro. Metabolism 51:1439–43
   PubMed Web of Science ®Google Scholar
• Yoosook C, Bunyapraphatsara N, Boonyakiat Y, Kantasuk C. (2000). Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine 6:411–19
   PubMed Web of Science ®Google Scholar
• Zhou TT, Zhu ZY, Wang C, et al. (2007). On-line purity monitoring in high-speed counter-current chromatography: Application of HSCCC-HPLC-DAD for the preparation of 5-HMF, neomangiferin and mangiferin from Anemarrhena asphodeloides Bunge. J Pharm Biomed Anal 44:96–100
   PubMed Web of Science ®Google Scholar
• Zierath JR, He L, Guma À, et al. (1996). Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180–9
   PubMed Web of Science ®Google Scholar
• Zuo YQ, Liu WP, Niu YF, et al. (2008). bis(α-Furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. J Pharm Pharmacol 60:1335–40
   PubMed Web of Science ®Google Scholar